Biomedical Engineering Reference
In-Depth Information
262. Allkemper, T.; Bremer, C.; Matuszewski, L.; Ebert, W.; Reimer, P. Contrast Enhanced Blood
Pool MR Angiography with Optimized Iron Oxides: Effect of Size and Dose on Vascular
Contrast Enhancement in Rabbits.
Radiology
2002,
223,
432-438.
263. Taupitz, M.; Wagner, S.; Schnorr, J.; Kravec, I.; Pilgrimm, H.; Bergmann Fritsch, H., et al.
Phase I Clinical Evaluation of Citrate Coated Monocrystalline Very Small Superparamagnetic
Iron Oxide Particles as a New Contrast Medium for Magnetic Resonance Imaging.
Invest.
Radiol.
2004,
39,
394-405.
264. Schoenberg, S. O.; Aumann, S.; Just, A.; Bock, M.; Knopp, M. V.; Johansson, L. O., et al.
Quantification of Renal Perfusion Abnormalities Using an Intravascular Contrast Agent (part 2):
Results in Animals and Humans with Renal Artery Stenosis.
Magn. Reson. Med.
2003,
49,
288-298.
265. Karczmar, G. S.; Fan, X.; AlHallaq, H.; River, J. N.; Tarlo, K.; Kellar, K. E., et al. Functional
and Anatomic Imaging of Tumor Vasculature: High Resolution MR Spectroscopic Imaging
Combined with a Superparamagnetic Contrast Agent.
Acad. Radiol.
2002,
9,
S115-S118.
266. Weishaupt, D.; Hetzer, F. H.; Ruehm, S. G.; Patak, M. A.; Schmidt, M.; Debatin, J. F. Three
Dimensional Contrast Enhanced MRI Using an Intravascular Contrast Agent for Detection
of Traumatic Intra-abdominal Hemorrhage and Abdominal Parenchymal Injuries: An Experi-
mental Study.
Eur. Radiol.
2000,
10,
1958-1964.
267. Gambarota, G.; Leenders, W.; Maass, C.; Wesseling, P.; van der Kogel, B.; van Tellingen, O.,
et al. Characterisation of Tumour Vasculature in Mouse Brain by USPIO Contrast Enhanced
MRI.
Br. J. Cancer
2008,
98,
1784-1789.
268. Affibody
First in Human Whole-body HER2-receptor Mapping Using Affibody Molecular
Imaging with ABY-025
, 2011 Available from:
http://www.afibody.com/en/News/News/First-
269. NIH; NCBI, Ed.; NCBI: Bethesda, 2004-2011.
270. Loebinger, M. R.; Kyrtatos, P. G.; Turmaine, M.; Price, A. N.; Pankhurst, Q.; Lythgoe, M. F.;
Janes, S. M. Magnetic Resonance Imaging Of Mesenchymal Stem Cells Homing to Pul-
monary Metastases Using Biocompatible Magnetic Nanoparticles.
Cancer Res.
2009,
69,
2267-8862.
271. Mathiasen, A. B.; Haack-Sorensen, M.; Kastrup, J. Mesenchymal Stromal Cells for Cardio-
vascular Repair: Current Status and Future Challenges.
Future Cardiol.
2009,
5,
605-617.
272. Sadan, O.; Melamed, E.; Offen, D. Bone-marrow-derived Mesenchymal Stem Cell Therapy
for Neurodegenerative Diseases.
Expert Opin. Drug Del.
2009,
9,
1487-1497.
273. Kuhn, N. Z.; Tuan, R. S. Regulation of Stemness and Stem Cell Niche of Mesenchymal Stem
Cells: Implications in Tumorigenesis and Metastasis.
J. Cell Phys.
2010,
222,
268-277.
274. Feng, B.; Chen, L. Review of Mesenchymal Stem Cells and Tumors: Executioner or Cocon-
spirator?
Cancer Biother. Radiopharm.
2009,
24,
717-721.
275. Lee, S.; Cha, E. J.; Park, K.; Lee, S. Y.; J.K., H.; Sun, I. C.; Kim, S. Y.; Choi, K.; Kwon, I. C.;
Kim, K.; Ahn, C. H. A Near-infrared-fluorescence-Quenched Gold-nanoparticle Imaging
Probe for In vivo Drug Screening and Protease Activity Determination.
Angew. Chem. Int. Ed.
Engl.
2008,
47,
2804-2807.
276. Xie, J.; Zhang, F.; Aronova, M.; Zhu, L.; Lin, X.; Quan, Q.; Liu, G.; Zhang, G.; Choi, K. Y.;
Kim, K.; Sun, X.; Lee, S.; Sun, S.; Leapman, R.; Chen, X. Manipulating the Power of an Addi-
tional Phase: A Flower-like Au-Fe
3
O
4
Optical Nanosensor for Imagin
g
Protease Expressions
In vivo.
ACS Nano.
2011,
5,
3043-3051.
277. Lin, X.; Xie, J.; Niu, G.; Zhang, F.; Gao, H.; Yang, M.; Quan, Q.; Aronova, M. A.; Zhang, G.;
Lee, S.; Leapman, R.; X., C. Chimeric Ferritin Nanocages for Multiple Function Loading and
Multimodal Imaging.
Nano Lett.
2011,
11,
814-819.